ROYCE & ASSOCIATES LP - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q4 2013$540,000
-0.6%
4,600
-11.5%
0.00%0.0%
Q3 2013$543,000
-89.0%
5,200
-91.0%
0.00%
-86.7%
Q2 2013$4,955,00057,5680.02%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2013
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders